aTyr Pharma (ATYR)

• Market cap: $76.6M
• 1 day: -5.54%
• 5 days: -11.18%
• 1 month: -20.95%
• 3 months: 5.89%
• 6 months: -17.81%
• Year to date: 2.96%
• 1 year: -78.88%
• 5 years: -83.23%
• 10 years: -98.89%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Employees: 58